Vytorin Label Adds Superiority Data Over Crestor
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approved the inclusion of new data on the cholesterol-lowering efficacy of the ezetimibe/simvastatin fixed-dose combination.
You may also be interested in...
Schering-Plough’s “Build The Base” Action Agenda May Include Acquisitions
Firm announces it is moving into the fourth phase of its five-point action agenda restructuring plan.
Schering-Plough’s “Build The Base” Action Agenda May Include Acquisitions
Firm announces it is moving into the fourth phase of its five-point action agenda restructuring plan.
Abbott/AstraZeneca Come Together Over Statin/Fibrate Combo
Two parallel programs have been initiated in search of the next combination cholesterol management drug.